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KESAN RAWATAN MADU TUALANG KE ATAS FIBROBLAS KELOID DAN 
NORMAL MANUSIA DAN PERKAITANNYA DENGAN PENGEKSPRESAN 
TGF-β 
  
ABSTRAK 
 
 Pembentukan parut keloid pada kulit manusia berlaku selepas trauma, 
pembedahan atau disebabkan kulit terbakar. Keloid terbentuk melangkaui kawasan yang 
terluka dan ciri ini membezakan keloid daripada parut hipertrofik. Teknik pembuangan 
keloid dilakukan disebabkan ketidakselesaan pertumbuhan keloid terutamanya pada 
kawasan yang terdedah. Walaubagaimanapun, pertumbuhan keloid biasanya berulang 
selepas pembedahan. Madu Tualang adalah madu tempatan yang didapati daripada 
pokok Tualang yang lebih dikenali dengan nama saintifiknya Koompassia excelsa yang 
boleh dijumpai di hutan hujan tropika Asia Tenggara. Madu Tualang adalah madu 
multiflora yang dihasilkan oleh Apis dorsata atau lebah Asia yang membuat sarang di 
atas pokok Tualang. Pemahaman terhadap rawatan keloid menggunakan madu masih 
terhad dan belum mendapat kata sepakat. Oleh itu, penyelidikan asas perlu dilakukan. 
Objektif-objektif penyelidikan ini adalah untuk menentukan keserasian madu Tualang 
kepada sel secara in vitro, untuk menentukan komposisi kimia madu Tualang, untuk 
mengkaji kesan komponen kimia madu Tualang tertentu pada proliferasi fibroblas secara 
in vitro dan melihat kesan ekspresi faktor pertumbuhan (TGF-β) terhadap keloid selepas 
dirawat dengan madu Tualang secara in vitro. Kultur fibroblas keloid dan normal 
dirawat dengan kepekatan madu Tualang yang berbeza dengan nisbah 1:2 bermula 
daripada 12.5% sehingga 0.10% dan ketoksikan sel diuji dengan ujian-ujian MTT dan 
xx 
 
LDH. Kandungan volatil madu Tualang dikenalpasti dengan menggunakan lima pelarut 
organik yang berbeza dan dianalisis dengan kaedah GC-MS. Tiga puluh lima jenis 
kandungan volatil dikenalpasti daripada pengekstrakan madu Tualang. Madu Tualang 
yang diekstrak dengan metanol digunakan untuk diuji pada sel fibroblas dan kesan sel 
proliferatif diuji dengan ujian MTS. Ekspresi TGF-β pada keloid yang tidak dirawat dan 
dirawat dengan madu Tualang diuji dengan TGF-β Immunoesei. Hasil kajian 
menunjukkan madu Tualang pada kepekatan yang tinggi (12.5%) adalah toksik terhadap 
sel fibroblas tetapi ketoksikan madu Tualang terhadap kulit fibroblas manusia semakin 
menurun selepas pencairan. Madu Tualang yang diekstrak dengan metanol telah 
menunjukkan kebolehannya untuk merencatkan proliferasi sel. Didapati asid lemak 
berkemungkinan menyumbang kepada kesan antiproliferatif ini. Ekspresi TGF-β1 dan 
TGF-β2 pada fibroblas keloid yang dirawat menurun secara signifikan berbanding 
fibroblas keloid yang tidak dirawat. Ini telah membawa kepada penemuan baru di mana 
madu berupaya merencatkan sintesis kolagen dan seterusnya menurunkan tahap TGF-β 
dalam keloid. Penemuan-penemuan ini berpotensi membantu untuk penyelidikan 
terhadap model haiwan secara in vivo juga untuk kajian dari segi mekanisme molekular 
pada masa akan datang.         
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EFFECT OF TUALANG HONEY TREATMENT ON HUMAN KELOID AND 
NORMAL FIBROBLAST AND ITS RELATIONSHIP WITH TGF-β 
EXPRESSION 
 
ABSTRACT 
 
 Keloid scar develops on the human skin after trauma, surgery or burn. Keloid 
grows beyond the boundaries of the wound site and is distinguishable from hypertrophic 
scar. Due to discomfort caused by keloid growth especially at exposed area, keloid 
excision might be needed. However, recurrence is common after surgical incision. 
Tualang honey is a local honey which is found on Tualang tree known as Koompassia 
excelsa found in Southeast Asia rainforests. Tualang honey is a multifloral honey which 
is produced by Apis dorsata or Asian rock bees that nested on the Tualang tree. There is 
no consensus and limited understanding in the keloid treatment using honey and 
therefore fundamental research is needed. The objectives of this study were to determine 
the degree of cytocompatibility of Tualang honey in vitro, to determine the chemical 
composition profile of Tualang honey, to investigate the effect of defined chemical 
components of Tualang honey on the proliferation of human skin fibroblasts in vitro and 
the effect on the expression of transforming growth factor-beta (TGF-β) in keloids after 
being treated with Tualang honey. The cultured keloid and normal fibroblasts were 
treated with several concentrations of Tualang honey ranging between 12.5% and 0.10% 
with 1:2 dilution followed by cytotoxicity testing using MTT and LDH assays. Volatile 
compounds of Tualang honey were identified based on five different organic solvents 
using Gas Chromatography-Mass Spectrometry (GC-MS) technique. Thirty five volatile 
xxii 
 
compounds have been identified from the extracts of Tualang honey. Methanol extract of 
Tualang honey was used to treat fibroblasts and the cell proliferative effect was 
determined by MTS assay. Expression of TGF-βs in untreated and honey treated keloid 
fibroblasts were determined using TGF-β Immunoassay. This study revealed that higher 
concentrations (12.5%) of Tualang honey was cytotoxic to fibroblasts cells but its 
toxicity to human fibroblasts reduced following dilution of the honey. Methanol extract 
of Tualang honey inhibited cell proliferation suggesting that its fatty acid contents may 
possess antiproliferative effect. TGF-β1 and TGF-β2 expressions in Tualang honey-
treated keloid fibroblasts were lower compared with the untreated keloid fibroblasts. 
This finding indicated that honey has the ability to reduce collagen synthesis in keloid 
and simultaneously decreased TGF-βs level in keloid represent a new discovery in this 
field. The above findings have potential to be investigated in animal model in vivo as 
well as for studies at the molecular mechanism levels.         
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CHAPTER 1 - RESEARCH BACKGROUND 
 
1.1 Skin Anatomy 
 
Human skin is made up of three main layers which are epidermis, dermis and 
subcutaneous layer (Figure 1.1). The largest organ in human is skin. Skin consists of 
many types of cells and structures. There are several functions of skin including 
protecting the body from environment, for example, sun exposure, against infection, 
avoiding excessive loss of water from the body by evaporation, protecting organs and 
tissues from mechanical damage, regulates temperature, excretion of excess salts, water 
and urea from the body (Naficy, 2000).   
Epidermis is the superficial layer of the skin. Epidermis is thicker on palms of 
hands and soles of feet compared to face and eyelids which have thinner epidermis 
(Wildcrafted’s natural skin care newsletter, 2004). Epidermis is made from cells called 
keratinocytes. Dermis is thicker than epidermis which consists of connective tissue. 
Fibroblasts can be found in dermal layer. Dermal layer contains sense organs such as 
touch, pressure, pain and temperature. Subcutaneous layer lies below the dermis which 
consists of loose connective tissue and fat. It acts as a protective cushion as well as for 
temperature regulation.     
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Figure 1.1. Anatomy of human skin which consists of three main layers; epidermis, 
dermis and subcutaneous tissue.                     (Adapted from: Naficy, 2000) 
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1.2 Definition of Scar 
 
 Scar formation is the result of natural healing process which occurs after wounds, 
trauma, burns, surgical incision, vaccinations or disease (Gauglitz et al., 2011; Edriss 
and Mueak, 2005). In order to close a wound, skin repairs itself from normal to scar 
tissue and thus prevents infection (Edriss and Mueak, 2005). There are several types of 
scar. Among common ones are keloid and hypertrophic scars (Figure 1.2). These two 
scars can be distinguished by its size and shape. Keloid scars are larger in size and 
extend beyond the margins of the original wound compared to hypertrophic scars which 
remains within the wound border (Jagadeesan and Bayat, 2007).  
Formation of scars can be characterized by an overproduction of extracellular 
matrix particularly collagen (Chin et al., 2004). Normal skin contains collagen bundles 
that are arranged parallel to the skin surface. However keloid consists of dense mass and 
randomly organized collagen and fibroblasts (Jagadeesan and Bayat, 2007). Fibroblast is 
a type of cell that synthesizes the extracellular matrix and a protein called collagen.  
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Figure 1.2. Keloid grows faster than hypertrophic scar whereas it proliferates to higher 
level of abnormality within short time frame and finally stabilized. Hypertrophic scar 
involves contraction or contractures but this condition does not occur in keloid. 
(Adapted from: BMJ Evidence Center, 2011)
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1.3 Expression of Growth Factors 
 
High expression of certain growth factors or cytokines commonly associates with 
excessive accumulation of collagen in keloid scar. One of the important cytokine 
involved in scar formation is transforming growth factor beta (TGF-β) (Tuan and 
Nichter, 1998). TGF-β is a group of cytokines which is also called as ‘The TGF-β 
superfamily’. It regulates epithelial cell growth and differentiation (Chin et al., 2004) 
and is found expressed by all cells (Chin et al, 2004). It can act either as a stimulator or 
inhibitor in cellular replication and control production of extracellular matrices (Streuli 
et al., 1993).  
There are several types of TGF-β where the most common ones are TGF-β1, 
TGF-β2 and TGF-β3. TGF-β1 and TGF-β2 are involved in promoting fibrosis and 
formation of scar while TGF-β3 can either induce or reduce scarring (Chin et al., 2004). 
From Figure 1.3, it shows that the formation of scar occurs due to the induction of TGF-
β1 by connective tissue growth factor (CTGF). In this study, TGF-β1 and TGF-β2 
expression from keloid were determined in vitro. Several treatments for keloid excision 
have been described including surgical, nonsurgical and combined modality treatment. 
Keloid treated with simple excision tends to recur and the use of laser is expensive 
(Kokoska and Prendiville, 2007). In this study, cultured keloid fibroblasts were treated 
with Tualang honey to study the ability of honey in reducing keloid scar. 
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Figure 1.3. Induction of TGF-β1 through connective tissue growth factors (CTGF) 
causes increase of fibroblast proliferation and leads to scar formation. [Abbreviations: 
ECM, extracellular matrix].   
                                         (Adapted from: Klass et al., 2009) 
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1.4 Tualang Honey 
 
For a long time, honey has been valued for its medicinal properties. Honey has 
been used to treat infections in various types of wounds including burns, diabetic ulcers, 
pressure ulcers, traumatic ulcers and Fournier’s gangrene (Molan, 2001). The antiseptic 
and antibacterial properties of honey have recently been explained at a chemical level 
(Jeffrey and Carlos, 1996).  
In Malaysia, one of the most common honey found is Tualang honey. The 
Tualang tree known as Koompassia excelsa is a majestic tree of the Southeast Asia 
rainforest best known for the disk-shaped honeycombs which hang from its horizontal 
branches. It is mostly found in lowland forests of Peninsular Malaysia, southern 
Thailand, northern Sumatra and Borneo, and can grow to heights greater than 85 meters. 
The trees are valued by the locals due to its honey. In fact, a standing Tualang tree is 
more valuable for its honey than if it were felled for its timber. The honey from the 
combs of this tree is known as Tualang honey and is produced by Apis dorsata or Asian 
rock bees (Tropical Rainforests, 2006).  
This study focused on two major fields which are basic pharmacology study and 
in vitro study. In the field of pharmacology, a spectrometry technique was carried out to 
identify its volatile compositions which have never been elucidated before. Meanwhile 
in vitro technique was done to determine the viability of cells and expression of growth 
factors in fibroblast cells, exposed to the Tualang honey.  
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1.5 Hypothesis 
 
Tualang honey is effective in treating keloid scar and is able to reduce expression 
of TGF-β in keloid. 
    
1.6 General Objective 
 
 To study the mechanism of healing capability of Tualang honey on keloid scar 
formation. 
 
1.7 Specific Objectives 
 
 To determine the degree of cytocompatibility of the Tualang honey using an in 
vitro study model. 
 To determine the composition profile of Tualang honey using GC-MS. 
 To investigate the effect of methanolic extraction of Tualang honey on the 
proliferation of human skin fibroblasts in vitro. 
 To determine the effect on the expression of transforming growth factor-beta 
(TGF-β) in keloid fibroblasts after treatment with Tualang honey using 
biochemical method.  
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CHAPTER 2 - LITERATURE REVIEW 
 
2.1 Keloid Scar 
2.1.1 Characteristic of Keloid 
  
 Keloid is a type of scar which extends beyond the boundaries of the original 
wound (Figure 2.1). It can spread to the surrounding skin by invasion. Clinical 
appearance of keloid is a raised growth and is usually related with pruritus and pain. 
Certain areas of the body such as sternum, deltoid (Kokoska and Prendiville, 2007) and 
the back (Edriss and Mueak, 2005) are susceptible to keloid formation. Some opinions 
conclude that motion and tension play a major role in the formation of keloid (Edriss and 
Mueak, 2005). Previous in vivo and in vitro studies have found that the increase of 
tension level has been shown to increase the production of fibroblasts and 
myofibroblasts (Edriss and Mueak, 2005).  
Keloid scars commonly occur only in humans. Keloid healing remains unravelled 
since the pathogenesis of biochemical mechanisms of keloid is still unknown (Vincent et 
al., 2008). Development of keloid contains atypical fibroblasts and consists of 
overabundant of extracellular matrix components include collagen, fibronectin and 
certain proteoglycans. During the early stage of granulation tissue, fibronectin 
production is high and collagen deposition is low. When granulation tissue matures, 
collagen production becomes high while fibronection is low (Babu et al., 1992).  
Collagen is a component of extracellular matrices which play various roles in 
mammals. There are 27 types of collagen that have been identified with specific α-chains 
which are encoded by more than 40 different genes (Ishida et al., 2006). Type I collagen 
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consists of two α1 chains and one α2 chain. Newly synthesized polypeptides of 
procollagen are cotranslationally transferred into the endoplasmic reticulum (ER). In 
order to ensure correct folding of collagen in the cell, several molecular chaperones are 
involved. These molecular chaperones include BiP/Grp78, Grp94, protein disulfide 
isomerase (PDI), prolyl 4-hydroxylase (P4H) and heat-shock protein of 47 kDa (HSP-
47).      
Increase of collagen mRNA expression, propyl-4 hydroxylase and fibronectin 
synthesis (Jagadeesan and Bayat, 2007) in keloid scar result in higher level of type III 
collagen deposition compared to normal (Kokoska and Prendiville, 2007; Jagadeesan 
and Bayat, 2007). Collagen deposition could result either from enhanced biosynthetic 
activity or reduced rate of degradation. This condition leads to an imbalance collagens in 
the dermis (Uitto and Kouba, 2000). Fibroblasts and myofibroblasts are responsible for 
the deposition of dense extracellular matrix which consists of collagen and 
glycosaminoglycans. Certain studies reported that level of fibronectin which is produced 
by fibroblasts has increased within keloids (Kokoska and Prendiville, 2007). Compared 
to normal fibroblasts, explanted keloid fibroblasts synthesize abnormal collagen 
deposition (Babu et al., 1992).    
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Figure 2.1. The characteristics of keloid mark its differences from hypertrophic scar. It is 
composed of disorganized type I and III collagens.     
                                     (Adapted from: Su et al., 2010)   
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2.1.2 Comparison between Keloid and Hypertrophic Scar 
 
 Keloid and hypertrophic scars are both benign proliferation of the dermis. 
Keloids occur genetically in approximately 10% of people with darkly pigmented skin. 
Even though keloid and hypertrophic scars look similar and are hard to differentiate 
because of an apparent lack of morphologic differences, they can be distinguished by 
their own special characteristics (Felice et al., 2009; Campaner et al., 2006). A keloid 
can be differentiated from a hypertrophic scar in which it grows beyond the boundaries 
of the original wound, continues to grow from time to time, is recurrent after surgical 
excision and does not regress spontaneously. However for hypertrophic scar, it remains 
within the boundaries of the original lesion, does not recur and often regresses 
spontaneously several months after the initial injury (Felice et al., 2009; Campaner et al., 
2006). Similarly, formation of keloid and hypertrophic scar is related to collagen 
deposition. Collagen deposition is increased in keloid and hypertrophic scars due to 
uncontrolled production of extracellular matrix and reduced degradation of procollagen 
polypeptide (Ueda et al., 2004). Besides that, keloids are characterized by the presence 
of thick, hyalinized collagen bundles with mucinous ground substance and relatively few 
fibroblasts while hypertrophic scars are characterized by nodular structures with fine 
randomly organized collagen fibers (Campaner et al., 2006). 
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2.1.3 Mechanism of Formation of Keloid Scar  
 
The specific mechanism of keloid formation is undetermined. One theory 
reported that allergic immunoglobulin E (IgE)-mediated response leading to a decreased 
percentage of mature cross-linked collagen and increased fraction of soluble collagen. A 
second theory stressed that either the deficiency of melanocyte-stimulating hormone 
(MSH) metabolism or excess accumulation of MSH such as during puberty and 
pregnancy (Edriss and Mueak, 2005) results in keloid formation. Recent study reported 
increased level of interleukin-6 (IL-6) expression and the role of insulin like growth 
factor-1 (IGF-1) and IGF-1 receptor increased the activity of keloid (Kokoska and 
Prendiville, 2007). 
 In the management of scars, one should know how to prevent scars and learn 
how to identify them immediately. In order to do this, a good understanding of wound 
healing and skin biomechanics is important (Santucci et al., 2001).  
 
2.2 Phases of Wound Healing 
 
Wound healing is a process that occurs after an injury which involves tissue 
repair and regeneration (Kumar et al., 2004; Adikwu and Enebeke, 2007). A wound is a 
break of the tissue continuity due to trauma or violence and if restoration of the wound 
site to normal condition occurred, the wound is considered as healed (Adikwu and 
Enebeke, 2007). Wound healing starts with inflammation and ends with scar formation 
(Kumar et al., 2004). Three phases are involved in wound healing which are 
inflammatory, proliferation and remodeling (Table 2.1). In the inflammatory phase, 
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blood coagulation, hemostasis, infiltration of leukocytes and cytokine release occur 
(Figure 2.2). More immune response cells migrate to the healing wound. During the 
proliferative phase, formation of epithelium occurs in order to close the wound surface 
together with the growth of granulation tissue to fill the wound space within hrs (Li et 
al., 2007; Adikwu and Enebeke, 2007). During this phase, cellular activity is dominant 
and the wound closes spontaneously by contraction with reepithelization occuring in 
early wound repair (Adikwu and Enebeke, 2007). There is also granulation tissue 
formation which involves fibroblasts proliferation, collagen deposition and development 
of new blood vessels (Figure 2.2).  
The final remodeling phase is also known as delayed primary closure (Adikwu 
and Enebeke, 2007). It takes place when the new tissue is already well-formed and 
begins to restore tissue structural integrity (Li et al., 2007). During this phase initial 
debridement of the wound for over a period of time followed by a formal closure of the 
wound by suturing or other mechanism are involved. This complex event includes 
extracellular matrix, cells, growth factors and cytokines (Adikwu and Enebeke, 2007). 
There are two most important factors in the process of scar tissue formation which are 
aggregation and proliferation of fibroblasts in the wound site; and the increase in the 
accumulation of other extracellular matrix components such as collagen (Kumar et al., 
2004). The major events that occur during this phase are the creation of a permeability 
barrier, the establishment of appropriate blood supply and reinforcement of injured 
dermal tissue (Li et al., 2007). Many cytokines are involved during this phase including 
insulin like growth factor (IGF). Contraction results in smaller appearance of scar tissue 
(Adikwu and Enebeke, 2007).  
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Table 2.1. Wound healing involves three main phases: Inflammation, proliferation and 
remodeling. Wound healing is associated with immune cellular response; which involves 
presence of several important cells. [Abbreviations: PDGF, platelet derived growth-
factor; TGF-β, transforming growth factor-beta; EGF, epidermal growth factor; VEGF, 
vascular endothelial growth factor; ECM, extracellular matrix; TNF-α, tumor necrosis 
factor-alpha; IL-1, interleukin-1].   
 
PHASES DAY PRESENCE OF CELLS/ CHARACTERISTICS 
Inflammation 0 – 6  Number of platelets increase and release many growth 
factors including PDGF, TGF-β, EGF and VEGF. 
 Neutrophils and macrophages strongly increased between 
day 2 and 3.  
Proliferation 1 – 14  Reepithelialization starts a few hours after lesion. 
 Neutrophils increase to a maximum level at day 2 and 
slowly decreased at day 6. 
 Macrophages increase to a maximum level at day 3 and 
decrease slowly until day 13. 
 Fibroblasts cells increase, produce a new extracellular 
matrix for cell growth.   
Remodeling 8 – 16   An attempt to recover the normal tissue structure. 
 Most vessels, inflammatory cells (macrophages and 
lymphocytes) and fibroblasts disappear from the wound site 
through migration, apoptosis or other unknown cell death 
mechanism. 
 Fibroblasts are transformed into myofibroblasts and act as 
contractile tissue. 
 ECM reorganization, cytokines (TNF-α, IL-1 and TGF-β) 
released 
 
                      (Adapted from: Mendonça and Coutinho-Netto, 2009) 
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Figure 2.2. Normal process of wound healing. It represents: 1) The activation of 
coagulation cascade cause cytokines release 2) An abundance of fibroblasts and ECM 
accumulation 3) Immature type III collagen of early wound is modified into mature type 
I collagen in mature phase. 
                                       (Adapted from: Su et al., 2010) 
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2.3 Fibroblasts Proliferation 
 
Fibroplasia is a process of formation of granulation tissue. It involves fibroblasts 
proliferation, migration into wound fibrin clot and production of new collagen and 
matrix proteins. Fibroblasts begin to proliferate at the wound edges. After several days, 
it starts to migrate into provisional matrix of the wound clot and form collagens, 
proteoglycans and elastin (Li et al., 2007). Fibronectin and collagen provide a reservoir 
for cytokines and growth factors and thus contribute to granulation tissue formation.  
Collagen is the most abundant protein in mammals. It plays various roles as a 
component of the extracellular matrices. Type I collagen is a typical fibril-forming 
collagen which is a major component of the extracellular matrix (ECM) whereas type IV 
collagen is a nonfibrillar network-forming collagen found in basement membranes 
(BMs) (Ishida et al., 2006). Collagen is crucial for various biological functions, and 
mutations of collagen are known to cause various collagen-related diseases including 
osteogenesis imperfecta and the Ehlers–Danlos syndrome (Myllyharju and Kivirikko, 
2004).  
Fibronectin is a glycoprotein that is initially secreted for the enhancement of 
fibroblast activity. Fibronectin allows fibroblasts to bind to extracellular matrix and thus 
produce adherent base for cell migration. Both PDGF and TGF-β can stimulate 
fibroblast migration and up-regulate the expression of integrin receptors (Li et al., 2007). 
On the other hand, fibrosis is a condition whereby abnormal and excessive accumulation 
of fibrous tissue, for example in the wound healing process following trauma or surgery. 
Fibrosis that occurs in the skin causes the formation of abnormal scars either 
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hypertrophic scars or keloids. This abnormal behavior can lead to other problems in 
tissue growth, function and movement (Campaner et al., 2006). 
 
2.4 Transforming Growth Factor-βeta (TGF-β) Expression 
2.4.1 Phases of TGF-β Secretion 
 
 TGF-β is known to play an important role in the pathogenesis of keloid and 
hypertrophic scarring via a distinct molecular mechanism (Chin et al., 2004). Cascade 
pathway takes place for tissue regeneration and repair process in fibrosis. It involves 
three main phases in which it begins with coagulation and inflammatory phase, 
formation of granulation tissue phase and ends with extracellular matrix deposition and 
termination of the response phase. Platelets and inflammatory cells released certain 
factors whereas these factors initiate the regeneration response (Frazier et al., 1996). 
TGF-β was determined to be as one of the initiators in these processes (Wahl, 1992).  
 
2.4.2 Stimulation of TGF-β in Relation to Other Growth Factors 
 
TGF-β level is elevated in tissue during normal wound repair processes and skin 
fibrotic disorders processes (Frazier et al., 1996). The biologically active TGF-β induces 
a variety of cell activities such as stimulation or inhibition of cell growth and 
differentiation depending on the cell type (Tang et al., 1994). It is found in most parts of 
the body and is involved in the scarring process (Shah et al., 1995). In addition, several 
actions of TGF-β have been found as a result of increased fibrotic tissue disorders. These 
include increased fibroblasts proliferation, increased synthesis of extracellular matrix 
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components such as fibronectin and type I collagen and decreased degradation of 
extracellular matrix due to stimulation of the synthesis of protease inhibitors (Frazier et 
al., 1996). 
 Previous study has indicated that with the induction of platelet-derived growth 
factor (PDGF) genes, TGF-β can stimulate the growth of various fibroblastic cell types 
(Frazier et al., 1996). Expression of TGF-β was found to occur during inflammatory 
phase whereas connective tissue growth factor (CTGF) was expressed during 
granulation tissue formation phase of tissue repair. These coordinate expressions help to 
functionally link both phases of this complex process (Frazier et al., 1996). 
Overexpression of TGF-β has been reported in scleroderma lesions which suggested that 
there is an association between TGF-β and the increased in collagen deposition (Frazier 
et al., 1996).  
Activator protein-1 (AP-1) is known as a key regulatory protein in TGF-ß1-
induced type I collagen synthesis in skin fibroblasts (Cho et al., 2008). Formation of 
keloid is largely associated to fibronectin and collagen production. Fibronectin 
production is influenced by many regulatory factors and one of them is TGF-β. TGF-β 
plays a role in the extracellular matrix where it regulates the deposition of collagen, 
fibronectin, proteoglycans, tenascins, thrombopondin (Streuli et al., 1993; Ignotz et al., 
1987) via transcriptional mechanism (Babu et al., 1992). 
 
2.4.3 Inactive and Active Form of TGF-β 
 
 Synthesis and activation of TGF-β’s family is a complex process. TGF-β is 
secreted from monocytes, lymphocytes and fibroblasts (Varga and Pasche, 2009) and is 
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synthesized in a latent form as large precursor molecules. When secreted, it is 
proteolytically cleaved from the precursor. Latent TGF-β is a large 390-412 amino acid 
precursor protein which is activated by proteolytic cleavage between amino acid into 
active TGF-β and Latency associated peptide (LAP) (Khalil N., 1999). The presence of 
TGF-β in tissue cannot be detected in a latent form (Frazier et al., 1996). Even after 
cleavage it remains in a noncovalent association with the precursor sequence, bound to 
the latency-associated peptide (Campaner et al., 2006; Tang et al., 1994) by plasmin-
dependent and plasmin-independent pathways (Bikfalvi, 1995). Most of the TGF-β in 
tissue and that is produced by cells in culture is in this latent form.  
TGF-β–latency associated peptide complex is usually stored in the extracellular 
matrix but TGF-β in this complex is inactive. This latent TGF-β must be activated to 
obtain the active TGF-β (Frazier et al., 1996) and thus TGF-β expression in culture cells 
can be detected. Activation of latent TGF-β involves catalyzes of the TGF-β by serine 
proteases, thrombospondin and cell-surface integrins (Varga and Pasche, 2009). In 
addition, it can also be activated through dissociation of the mature form from the TGF-β 
complex in vitro (Olofsson et al., 1992). Once released from this complex, TGF-β1 is 
active and can bind to its cellular receptor.  
From Figure 2.3, TGF-β depot is at the extracellular matrix whereas cytokine is 
sequestered in a latent form here. Latent TGF-β is catalyzed by alpha v beta 6 (αvβ6) 
integrin on epithelial cell membranes into active TGF-β. Active TGF-β then binds to 
serine/threonine kinase cell surface receptors that phosphorylate downstream SMAD2/3. 
SMAD pathway is an intracellular signaling pathway that TGF-β family member signal 
through (Wikipedia, 2011, Yu et al., 2006). The term ‘SMAD’ is derived from a 
combination of homologue genes found in Caenorrhabditis elegans, SMA, and 
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Drosophila melanogaster, MAD (Yu et al., 2006). Phosphorylated SMAD2/3 form a 
complex with SMAD4 and accumulates within the nucleus resulting in transcription. 
Endogenous negative regulator includes SMAD7 inhibits TGF-β signaling by 
sequestering SMAD2 and SMAD3 inside the nucleus.  
TGF-β can also induce cellular responses, such as EMT (epithelial-mesenchymal 
transition), via SMAD-independent pathways involving the kinases JNK (Jun N-terminal 
kinase), p38, PI3K (Phosphoinositide 3 kinase), c-Abl (c-Abelson) and TAK1 (TGF-β-
activated kinase 1). Degradation of the TGF-β is regulated by the uptake of the TGF-β 
receptor–ligand complex into caveolin-lined endosomes. Excessive TGF-β activity or 
intracellular SMAD signaling results in collagen overproduction and fibrosis (Varga and 
Pasche, 2009). TGF-β1 is liberated by extremes of pH and heat in vitro as well as by 
proteases such as furin and plasmin (Gleizes et al., 1997; Khalil, 1999). 
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Figure 2.3. Mechanism of TGF-β signalling pathway involves several components in 
order to activate TGF-β, transcription and degradation process and profibrotic responses. 
           (Adapted from: Varga and Pasche, 2009) 
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2.5 Treatment of Keloid Scar 
 
 Effective treatment of fibrotic diseases is very limited. Despite the fact that there 
is a wide array of options such as corticosteroids, radiation, lasers, surgery and 
interferon, treatments are clinically challenging since recurrence of keloids after 
treatment is frequent, varying from 45 to 100% (Campaner et al., 2006).  There are 
several ways in managing keloid. Prevention of the inflammation extension can be done.  
Anti-inflammatory agents such as intralesional corticosteroids which act by inhibiting 
fibroblast growth and decreasing alpha-2 macroglobulin levels and synthetic 
glucosteroids are commonly used in the treatment of keloid scars. Other than that, this 
inflammatory response can be regulated before, during or after inflammatory gene 
expression. Transcription factor such as nuclear factor-kB (NF-kB) is activated before 
gene expression while inducible enzyme such as cyclo-oxygenase (COX) is regulated 
after gene expression. Nonsteroid anti-inflammatory drugs (NSAIDs) inhibit either the 
NF-kB pathway or COX activity (Edriss and Mueak, 2005).  
Another possible approach is inhibition of growth factor. TGF-β family 
especially TGF-β1 isoform is a key mediator of tissue fibrosis (Jagadeesan and Bayat, 
2007). An animal model study suggested that treatment of fibrotic scarring can be done 
either by blocking the effects of TGF-β1 and TGF-β2 or by administration of TGF-β3 
(Shah et al., 1995). In an attempt to reduce scarring, anti- TGF-β1 antibody may help to 
treat keloid either by inhibition of collagen synthesis by blocking TGF-β1 or by 
degeneration of types 1 and 3 collagens (Jagadeesan and Bayat, 2007). A previous study 
by Shah et al. (1995) has found that the addition of neutralizing antibody to TGF-β1 and 
24 
 
TGF-β2 to wounded adult rodents helped in scar reduction. Suppression of SMAD3 
signalling may also lead to inhibition of keloid fibroblasts (Phan et al., 2005). 
In addition, application of honey to scars may contribute to an alternative way of 
reducing a scar. A previous study has revealed the effectiveness of honey in wound 
healing for almost all types of wounds (Medhi et al., 2008). Therefore, it is possible that 
honey can help to minimize scarring without any surgical interventions. Clinical 
observation has found that sucrose either with or without antiseptic supplementation was 
able to initiate granulation tissue formation (Knutson et al., 1981). In addition, clinical 
studies have suggested that honey or sucrose may lower the incidence of keloid and 
hypertrophic scars (Kossi et al., 2001, Knutson et al., 1981). In keloid fibroblast culture, 
sucrose caused a clear decrease in proα1(I) collagen and a slight decrease in proα1(III) 
collagen mRNA level (Kossi et al., 2001) while mannose may have value in the 
prevention or treatment of abnormal scarring since it decreases type I collagen gene 
expression and synthesis as well as decreases type I/III collagen ratio (Kossi et al., 
2004).  
 
2.6 Honey and its Properties 
2.6.1 Properties and Composition of Honey 
 
Several beneficial properties of honey make honey a preferred choice for human. 
Honey has been used as a source of food since million of years ago by Paleolithic 
humans (Eaton and Eaton, 2000). Honey varies from one type to another in terms of 
geography, botany, floral origin, species of bees, age of honey and method of honey 
collection. Since ancient times, honey has been valued for its medicinal properties. 
